Moxazocine

Moxazocine is an opioid analgesic that is an antagonist at the kappa opioid receptor. It was developed in the 1970s by Dainippon Pharmaceutical.

Pharmacology

Moxazocine is a kappa opioid receptor antagonist. It is related to pentazocine, a mixed agonist/antagonist at the mu opioid receptor and kappa opioid receptor, but moxazocine is much more potent at the kappa receptor and acts as an antagonist rather than an agonist.

Clinical use

Moxazocine was developed as an analgesic, but it has not been widely used for this purpose. It has been used in research to investigate the role of the kappa opioid receptor in pain and other physiological functions.

Side effects

Like other kappa opioid receptor antagonists, moxazocine can cause a number of side effects, including sedation, dizziness, and nausea. It can also cause psychotomimetic effects, such as hallucinations and delusions, particularly at high doses.

See also

• Opioid receptor
• Kappa opioid receptor
• Opioid antagonist
• Analgesic

Moxazocine Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski